Authors: SCHRIJVERS D PRONK L HIGHLEY M BRUNO M LOCCITONELLI D DEBRUIJN E VANOOSTEROM AT VERWEIJ J VERMORKEN JB

Citation: D. Schrijvers et al., SEQUENCE-DEPENDENT PHARMACOKINETICS (PK) OF IFOSFAMIDE (I) COMBINED WITH DOCETAXEL (D), European journal of cancer, 34, 1998, pp. 176-176

Authors: MENDIOLA C CASTELLANO D GOMEZ H PEREZGRACIA JL ARCEDIANO A GOMEZMARTIN C PRONK L CORTESFUNES H

Citation: C. Mendiola et al., PHASE I II TRIAL OF ESCALATING-DOSE OF CYCLOPHOSPHAMIDE (C) IN COMBINATION WITH FIXED-DOSE OF PACLITAXEL (T) PLUS CISPLATIN (P) IN ADVANCEDOVARIAN-CANCER (AOC)/, Annals of oncology, 9, 1998, pp. 324-324

Authors: VASEY PA PRONK L TWELVES C SPARREBOOM A WILSON P GORDON RJ OSTERWALDER B VERWEIJ J

Citation: Pa. Vasey et al., PHASE-I AND PHARMACOKINETIC STUDY OF XELODA(TM) (CAPECITABINE) IN COMBINATION WITH DOCETAXEL, European journal of cancer, 33, 1997, pp. 1113-1113

Authors: STOUTHARD JML GOEY H DEVRIES EGE DEMULDER PH GROENEWEGEN A PRONK L STOTER G SAUERWEIN HP BAKKER PJM VEENHOF CHN

Citation: Jml. Stouthard et al., RECOMBINANT HUMAN INTERLEUKIN-6 IN METASTATIC RENAL-CELL CANCER - A PHASE-II TRIAL, British Journal of Cancer, 73(6), 1996, pp. 789-793

Authors: PRONK L SHRIJVERS D LOCCITONELLI D VERWEIJ J VANOOSTEROM AT

Citation: L. Pronk et al., PHASE-I STUDY OF DOCETAXEL AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SOLID TUMORS, European journal of cancer, 31A, 1995, pp. 961-961

Authors: VANDOORNUM GJJ PRINS M PRONK L COUTINHO RA DILLNER J

Citation: Gjj. Vandoornum et al., A PROSPECTIVE-STUDY OF ANTIBODY-RESPONSES TO DEFINED EPITOPES OF HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 IN RELATIONSHIP TO GENITAL AND ANORECTAL PRESENCE OF HPV DNA, Clinical and diagnostic laboratory immunology, 1(6), 1994, pp. 633-639